ChromaCode Inc, a molecular diagnostics company, has appointed co-founder Alex Dickinson executive chairman.
Dickinson joins the company from Illumina, where he was senior vice president of strategic initiatives.
ChromaCode recently raised $12 million in Series B funding to fuel development and establish commercial infrastructure for its High-Definition Polymerase Chain Reaction technology (HDPCR) . The software and assay technology makes use of existing instruments and digital...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In



